Patents by Inventor Collynn Woeller

Collynn Woeller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10548911
    Abstract: Disclosed are methods of treating fibrosis in a patient in need thereof that includes administering to the patient an amount of an active agent, as identified herein, that is therapeutically effective to inhibit myofibroblast formation and thereby treat the fibrosis. Also disclosed is a recombinant cell line that includes a recombinant gene that expresses a detectable expression product in a dose-dependent response to TGF?, as well as methods of identifying a compound that inhibits TGF?-mediated expression of the detectable expression product.
    Type: Grant
    Filed: June 16, 2015
    Date of Patent: February 4, 2020
    Assignee: University of Rochester
    Inventors: Richard P. Phipps, Collynn Woeller
  • Publication number: 20170216332
    Abstract: Disclosed are methods of treating fibrosis in a patient in need thereof that includes administering to the patient an amount of an active agent, as identified herein, that is therapeutically effective to inhibit myofibroblast formation and thereby treat the fibrosis. Also disclosed is a recombinant cell line that includes a recombinant gene that expresses a detectable expression product in a dose-dependent response to TGF?, as well as methods of identifying a compound that inhibits TGF?-mediated expression of the detectable expression product.
    Type: Application
    Filed: June 16, 2015
    Publication date: August 3, 2017
    Applicant: UNIVERSITY OF ROCHESTER
    Inventors: Richard P. Phipps, Collynn Woeller